| abstract |
The present invention relates to a compound having the general formula (V), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, n n n n n n n n n n which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed. |